<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0152">Other immunotherapeutic approaches entail ‘replacement of the endogenous adaptive immunity’ by: 1. adoptive transfer of genetically engineered T cells that can either express a canonical HLA class I restricted T cell receptor (TCR); 2. administering chimeric antigen receptor (CAR-T cells) 
 <xref rid="JVEv5-bib-0061" ref-type="bibr">[61]</xref>; and 3. using therapeutic monoclonal or bi-specific antibodies.
</p>
